Better Survival in BRCA-Mutated Breast Cancer With Neoadjuvant Olaparib-Chemo Combo

(MedPage Today) -- Overall survival (OS) in BRCA-mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to neoadjuvant chemotherapy despite no improvement in pathologic response, a small prospective study showed...